Form 4: Processa Pharmaceuticals Executive Wendy Guy Reports Stock Transactions
SEC Form 4 Filing
Wendy Guy, Chief Administrative Officer of Processa Pharmaceuticals, reports the acquisition and disposal of common stock and restricted stock units.
Summary
- On April 5, 2024, Wendy Guy acquired 1,675 shares of common stock and disposed of 368 shares at $2.79.
- On July 10, 2024, she acquired 644 shares of common stock and disposed of 220 shares at $1.71.
- As of the latest report, Wendy Guy directly owns 11,857 shares of common stock and indirectly owns 8,335 shares through CorLyst, LLC.
- She also holds 24,914 restricted stock units, which vest at various dates and upon achievement of certain performance goals.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting stock transactions, so it doesn't inherently convey positive or negative sentiment. It's a neutral disclosure.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, as required by the SEC. It provides transparency into the trading activities of insiders, which can be relevant to investors.
Stakeholder Impact
- Shareholders may be interested in the trading activity of company insiders as it can provide insights into management's perspective on the company's value and prospects.
Key Dates
| Date | Description |
|---|---|
| 04/05/2024 | Acquisition of 1,675 common stock shares and disposal of 368 common stock shares at $2.79. |
| 07/10/2024 | Acquisition of 644 common stock shares and disposal of 220 common stock shares at $1.71. |
| 08/02/2024 | Date of signature for the Form 4 filing. |
Keywords
Form 4, Processa Pharmaceuticals, Wendy Guy, Stock Transactions, Restricted Stock Units, Beneficial Ownership, PCSA
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.